Emona Biopharma Enters Partnership with Keystonemab to Co-develop Multiple High-Value Generics
Collaboration will leverage Keystonemab’s AI platform to identify novel synergistic drug combinations July 15, 2021 Utrecht, The Netherlands. – Keystonemab B.V., a privately-held company developing state-of-the-art artificial intelligence (AI) and big-data analytics platform for drug…